These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 9690440

  • 1. von Willebrand factor proteolysis and doxycycline in thrombotic thrombocytopenic purpura.
    Raife TJ, Aster RH.
    Lancet; 1998 Jul 25; 352(9124):324. PubMed ID: 9690440
    [No Abstract] [Full Text] [Related]

  • 2. Doxycycline, gastrointestinal bleeding, and thrombotic microangiopathy.
    Izzedine H, Launay-Vacher V, Mercadal L, Vernant JP, Deray G.
    Am J Hematol; 2004 Nov 25; 77(3):319. PubMed ID: 15495239
    [No Abstract] [Full Text] [Related]

  • 3. [The changes in von Willebrand factor multimer in a course of thrombotic thrombocytopenic purpura].
    Saitoh M, Wada H, Tanigawa M, Tamaki S, Masuya M, Minami N, Deguchi K, Shirakawa S, Tatewaki W, Takahashi H.
    Rinsho Ketsueki; 1991 Sep 25; 32(9):1006-8. PubMed ID: 1942536
    [Abstract] [Full Text] [Related]

  • 4. von Willebrand factor multimeric levels and patterns in patients with severe preeclampsia.
    Thorp JM, White GC, Moake JL, Bowes WA.
    Obstet Gynecol; 1990 Feb 25; 75(2):163-7. PubMed ID: 2300343
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. von Willebrand factor proteolysis in thrombotic thrombocytopenic purpura.
    Fulan M.
    Blood; 1999 Nov 15; 94(10):3611-2. PubMed ID: 10610117
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. von Willebrand factor in thrombotic thrombocytopenic purpura.
    Moake JL.
    Blood; 1986 May 15; 67(5):1523-6. PubMed ID: 3486016
    [No Abstract] [Full Text] [Related]

  • 9. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
    Moake JL.
    Prog Clin Biol Res; 1990 May 15; 337():135-40. PubMed ID: 2191307
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Blood coagulation disorders in thrombotic thrombocytopenic purpura--with special reference to a von Willebrand factor abnormality].
    Takahashi H, Tatewaki W, Hanano M, Takizawa S, Shibata A, Nakamura T.
    Rinsho Byori; 1987 Sep 15; Spec No 73():120-33. PubMed ID: 3501812
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abnormal interaction between platelets and von Willebrand factor in patients with TTP.
    Rock G, Tittley P, Taylor RJ.
    Prog Clin Biol Res; 1990 Sep 15; 337():129-33. PubMed ID: 2162061
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Significance of endothelial deposition of von Willebrand factor in thrombotic thrombocytopenic purpura: autopsy findings of a case complicated with systemic lupus erythematosus.
    Ono T, Kawaguchi K, Onaka H, Ueda S, Inui T, Nagai H, Matsuo T, Kuwahara T.
    Nihon Jinzo Gakkai Shi; 1993 Jan 15; 35(1):79-82. PubMed ID: 8336404
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Caplacizumab (Cablivi) for iTTP.
    Med Lett Drugs Ther; 2020 Oct 19; 62(1609):163-164. PubMed ID: 33429409
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
    Peyvandi F, Callewaert F.
    N Engl J Med; 2016 Jun 23; 374(25):2497-8. PubMed ID: 27332911
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.